Current HIV/AIDS Reports

Papers
(The median citation count of Current HIV/AIDS Reports is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Adventures in COVID-19 Policy Modeling: Education Edition69
Spiraling Risk: Visualizing the multilevel factors that socially pattern HIV risk among gay, bisexual & other men who have sex with men using Complex Systems Theory51
Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review50
Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?49
Challenges and Opportunities in Big Data Science to Address Health Inequities and Focus the HIV Response46
Feasibility and Impact of Community Pharmacy and Novel Pick-up Points for Antiretroviral Therapy Pre-exposure Prophylaxis Initiation and Continuation in Low and Middle-income Countries42
Syndemic Theory and Its Use in Developing Health Interventions and Programming: A Scoping Review42
Validity of Digital Assessments in Screening for HIV-Related Cognitive Impairment: a Review34
Differentiated Service Delivery Models for Maintaining HIV Treatment and Prevention Services During Crisis and Disease Outbreaks: Lessons from the COVID-19 Pandemic31
Interventions to Improve Adolescent HIV Care Outcomes29
Ethical Perspectives in Using Technology-Enabled Research for Key HIV Populations in Rights-Constrained Settings29
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?27
Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States25
Consolidated Overview of Notifiable Adverse Events in the U.S. President’s Emergency Plan for AIDS Relief’s Voluntary Medical Male Circumcision Program Through 202024
More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure24
Risk Compensation in Voluntary Medical Male Circumcision Programs24
Intestinal Microbiota and Aging in People with HIV—What We Know and What We Don’t23
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa22
Technology-Delivered Intervention Strategies to Bolster HIV Testing22
Current Status of HIV-Stigma Reduction Interventions: A Need to Address the Root Causes at Multiple Levels22
Risk-Based Screening Tools to Optimise HIV Testing Services: a Systematic Review22
Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy21
PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice20
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program20
Update on Central Nervous System Effects of HIV in Adolescents and Young Adults20
Future of bNAbs in HIV Treatment17
Voluntary Medical Male Circumcision for HIV Prevention: a Global Overview17
Sex Differences in Metabolic Disorders of Aging and Obesity in People with HIV16
A Review of Serious Gaming as an Intervention for HIV Prevention16
Medicinal Plant and Traditional Knowledge-guided Strategies to Combat HIV Persistence15
VMMC Programmatic Successes and Challenges: Western Kenya Case Study15
Transition to Adult Care for Young People Living with HIV15
Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy14
Genomic Exploration of the Brain in People Infected with HIV—Recent Progress and the Road Ahead14
Update on Vaccination Recommendations for Adults with HIV14
Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era14
Awareness of Heightened Sexual and Behavioral Vulnerability as a Trigger for PrEP Resumption Among Adolescent Girls and Young Women in East and Southern Africa14
Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions14
HIV Prevention Tools Across the Pregnancy Continuum: What Works, What Does Not, and What Can We Do Differently?14
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups13
Intervention Approaches to Address Intimate Partner Violence and HIV: a Scoping Review of Recent Research13
Mpox and HIV: a Narrative Review13
PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa13
Long-Acting Injectable Antiretroviral Therapy for Treatment of Human Immunodeficiency Virus: A Review13
Fatty Liver Disease: Enter the Metabolic Era12
Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations12
The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies12
Strategies for Hepatitis B Virus Prevention in People Living with HIV11
Advances in HIV Research Using Mass Cytometry11
Challenges of HIV Management in an Aging Population11
Voluntary Medical Male Circumcision to Reduce HIV Acquisition and Transmission11
Reporting Individual-Level Research Results from Neurocognitive and Psychological Research in People Living with HIV: Lessons from Dementia Research10
Adherence and HIV Protection Thresholds for Emtricitabine and Tenofovir Disoproxil Fumarate Preexposure Prophylaxis among Cisgender Women: A Systematic Review10
Implementation Science for HIV Prevention and Treatment in Indigenous Communities: a Systematic Review and Commentary10
The End Is in Sight: Current Strategies for the Elimination of HIV Vertical Transmission9
The Intersection of HIV and Syphilis: Update on the Key Considerations in Testing and Management9
A Perspective on Home-Based Sexual Health Care: Evidence, Access, and Future Directions9
Updates on HIV and Kidney Disease9
Addressing HIV and Substance Use Health Disparities among Racial/Ethnic Minority Individuals8
Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places8
The Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV8
Improving Communication: A Narrative Synthesis of Interventions for HIV Disclosure to Pediatric Populations8
Integrated Care Models: HIV and Substance Use8
Peer-Led Adjunctive Interventions for Increasing the Reach of HIV Prevention and Care Interventions to Latino/x/e Men Who Have Sex with Men: a Scoping Review7
Learning from Persistent Viremia: Mechanisms and Implications for Clinical Care and HIV-1 Cure7
Pharmacological and Behavioral Interventions to Mitigate Premature Aging in Patients with HIV7
Central Nervous System Impact of Perinatally Acquired HIV in Adolescents and Adults: an Update7
The New Era of Long-Acting Antiretroviral Therapy: When and Why to Make the Switch6
Social Determinants of Disease: HIV and COVID-19 Experiences6
COVID-19 Outcomes and Risk Factors Among People Living with HIV6
Correction to: A Review of Interventions to Enhance HIV Medication Adherence6
Does Voluntary Medical Male Circumcision Reduce HIV Risk in Men Who Have Sex with Men?6
Transgender Individuals and Digital Health6
Opportunities to Optimize Outcomes of Diagnosis and Treatment of HIV and Syphilis in Pregnancy: the Quest to Eliminate Maternal and Vertical Transmission6
Peer Approaches to Improve HIV Care Cascade Outcomes: a Scoping Review Focused on Peer Behavioral Mechanisms6
HIV Prevention in Syringe Service Programs Since the Start of COVID-19: Where Do We Go From Here?6
CNS Considerations in ART Simplification Strategies5
Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV5
Policies and Practices Facilitating Access to and Uptake of HIV Testing Services among Adolescents in Sub-Sahara Africa: A Narrative Review5
Current Interventions for People Living with HIV Who Use Alcohol: Why Gender Matters5
The Role of p53 in HIV Infection5
Overcoming Vaccine Hesitancy for Future COVID-19 and HIV Vaccines: Lessons from Measles and HPV Vaccines5
Challenges and Solutions to STI Control in the Era of HIV and STI Prophylaxis5
Point-of-Care Syphilis Testing: Implementation and Future Direction5
How Does Voluntary Medical Male Circumcision Reduce HIV Risk?5
Paradata: Measuring Engagement in Digital HIV Interventions for Sexual and Gender Minorities4
Running with Scissors: a Systematic Review of Substance Use and the Pre-exposure Prophylaxis Care Continuum Among Sexual Minority Men4
Metabolic Complications Associated with Use of Integrase Strand Transfer Inhibitors (InSTI) for the Treatment of HIV-1 Infection: Focus on Weight Changes, Lipids, Glucose and Bone Metabolism4
Antimicrobial Resistance in Curable Sexually Transmitted Infections4
Sustaining HIV Research in Resource-Limited Settings Using PLAN (People, Learning, Adapting, Nurturing): Evidence from the 4 Youth by Youth Project in Nigeria4
Cannabis Use in HIV: Impact on Inflammation, Immunity and the Microbiome4
Implementation Strategies for Digital HIV Prevention and Care Interventions for Youth: A Scoping Review4
Applying Behavioural Insights to HIV Prevention and Management: a Scoping Review4
0.16813206672668